The Spectrum of Antecedent Infections in Guillain-Barre Syndrome
Neurol 51:1110-1115, Jacobs,B.C.,et al, 1998
Neutralizing Antibodies to Interferon B-1a and Interferon B-1b in MS Patients are Cross-Reactive
Neurol 51:1698-1702, Khan,O.A. & Dhib-Jalbut,S., 1998
Ion Channels and Neurological Disease:DNA Based Diagnosis is Now Possible,and Ion Channels May be Important in Common Paroxysmal Disorders
JNNP 65:427-431, Hanna,M.G.,et al, 1998
Randomized,Double-Blind,Placebo-Controlled Trial of Pergolide in Restless Leg Syndrome
Neurol 51:1599-1602, Earley,C.J.,et al, 1998
Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998
Utility of Anti-Hu Antibodies in the Diagnosis of Paraneoplastic Sensory Neuropathy
Ann Neurol 44:976-980, Molinuevo,J.L.,et al, 1998
Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse
Headache 38:478-480, Nighoghossian,N.,et al, 1998
Morvan's Fibrillary Chorea: A Paraneoplastic Manifestation of Thymoma
JNNP 65:857-862, Lee,E.K.,et al, 1998
Herpes Simplex Encephalitis (HSE) and the Immunocompromised: A Clinical and Autopsy Study of HSE in the Settings of Cancer and Human Immunodeficiency Virus-Type 1 Infection
Hum Pathol 29:215-222, Schiff,D. &Rosenblum,M.K., 1998
Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997
Laboratory Evaluation in the Diagnosis of Lyme Disease
Ann Int Med 127:1109-1123, 1106-11081997., Tugwell,P.,et al, 1997
CSF Findings in Children with Lyme Disease-Associated Facial Nerve Palsy
Arch Pediatr Adolesc Med 151:1224-1228, 11831997., Belman,A.L.,et al, 1997
Anticytokine Antibodies in Beta Interferon-Trated MS Patients and the Need for Testing
Neurol 49:647-650, Pachner,A.R., 1997
Calcium Channels in Neurological Disease
Ann Neurol 42:275-282, Greenberg,D.A., 1997
Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997
Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997
Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997
Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997
Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997
Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997
Electrophysiologic Findings in Multifocal Motor Neuropathy
Neurol 48:700-707, Katz,J.S.,et al, 1997
Subdural Hematoma and Lupus Anticoagulants
Stroke 28:646-648, Moll,S.,et al, 1997
IgG Anticardiolipin Antibody Titer>40 GPL & Risk of Subseq Thrombo-Occlusive Events & Death
Stroke 28:1660-1665, Levine,S.R.,et al, 1997
Frequency and Significance of Antinuclear Antibodies in Multiple Sclerosis
Neurol 49:857-861, Collard,R.C.,et al, 1997
Chorea in the Antiphospholipid Syndrome
Medicine 76:203-212, Cervera,R.,et al, 1997
Prevalence and Signification of Antinuclear and Anticardiolipin Antibodies in Patients with Epilepsy
Am J Med 103:33-37, Verrot,D.,et al, 1997
Cat-Scratch Encephalopathy
Neurol 49:876-878, Wheeler,S.W.,et al, 1997
Motor Neuron Syndromes in Cancer Patients
Ann Neurol 41:722-730, 7031997., Forsyth,P.A.,et al, 1997
Clinicopath Conf
Hodgkin's Disease, Paraneoplastic Cerebellar Degeneration, Case 21-1997, NEJM 337:115-12297., , 1997
Paraneoplastic Cerebellar Degeneration
Arch Int Med 157:1258-1262, Bolla,L.&Palmer,R.M., 1997
Paraneoplastic Encephalomyelitis:An Update of the Effects of the Anti-Hu Immune Response on the Nervous System & Tumour
JNNP 63:133-136, Voltz,R.D.,et al, 1997
Serum Autoantibodies in Childhood Opsoclonus-Myoclonus Syndrome:Analysis of Antigenic Targets in Neural Tissues
J Pediatr 130:878-884, 8851997., Connolly,A.M.,et al, 1997
Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997
Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Cerebral Venous Thrombosis and Anticardiolipin Antibodies
Stroke 28:2363-2369, Carhaupoma,J.R.,et al, 1997
Small-Vessel Vasculitis
NEJM 337:1512-1523, Jennette,J.C.&Falk,R.J., 1997
Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997
Multifocal Motor Neuropathy, Serum IgM Anti-GM1 Ganglioside Antibodies Detected Using Linkage of GM1 to ELISA Plates
Neurol 49:1289-1292, Pestronk,A.&Choksi,R., 1997
CSF Antigliadin Antibodies and the Ramsay Hunt Syndrome
Neurol 49:1131-1133, Chinnery,P.F.,et al, 1997
Anticardiolipin Antibodies & the Risk of Recurrent Thrombo-Occlusive Events & Death
The Antiphospholipid Antibodies & Stroke Study Group, Neurol 48:91-9497., , 1997
The Natural Course of Cerebral Lesions in Sneddon Syndrome
Arch Neurol 54:53-60, Tourbah,A.,et al, 1997
Diagnosis of AIDS-Related Focal Brain Lesions
Neurol 48:687-694, Antinori,A.,et al, 1997
Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997
Adult-Onset Subacute Sclerosing Panecephalitis:Case Reports and Review of the Literature
Mov Dis 12:342-353, Singer,C.,et al, 1997
Cranial Nerve Enhancement on Three-Dimentional MRI in Miller Fisher Syndrome
Neurol 47:1601-1602, Nagaoka,U.,et al, 1996
Zoster Myelitis:Improvement with Antiviral Therapy in Two Cases
Neurol 47:929-931, deSilva,S.M.,et al, 1996
Clinicopath Conf
Q Fever, Acute (with Cerebellar and Meningeal Involvement) , Case 38-1996, NEJM 335:1829-1834., , 1996